Shanghai Haohai Biological Technology Co., Ltd. (FRA:5HB)
2.940
+0.020 (0.68%)
At close: Dec 5, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Medical Aesthetics and Wound Care | 1.06B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical Aesthetics and Wound Care Growth | 41.90% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Ophthalmic | 928.21M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Ophthalmic Growth | 20.57% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Orthopedic | 476.09M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Orthopedic Growth | 22.56% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Anti-Adhesion and Hemostatic | 141.76M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Anti-Adhesion and Hemostatic Growth | -19.98% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 46.39M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | -0.54% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| China | 2.20B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | 27.52% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Countries | 196.77M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Countries Growth | 23.11% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe | 136.05M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Growth | -3.38% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States | 120.28M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 15.97% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United Kingdom | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United Kingdom Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|